AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹368 Cr | ₹355 Cr | ₹279 Cr | ₹232 Cr | ₹257 Cr |
What is the latest Total Non-Current Liabilities ratio of AARTI DRUGS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹368 Cr |
| Mar2024 | ₹355 Cr |
| Mar2023 | ₹279 Cr |
| Mar2022 | ₹232 Cr |
| Mar2021 | ₹257 Cr |
How is Total Non-Current Liabilities of AARTI DRUGS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹368 Cr | 3.81 | |
| Mar2024 | ₹355 Cr | 27.08 | |
| Mar2023 | ₹279 Cr | 20.58 | |
| Mar2022 | ₹232 Cr | -9.97 | |
| Mar2021 | ₹257 Cr | - | |
Compare Total Non-Current Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹4,226.7 Cr | -2.5% | -9% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -2.5% |
-9% |
-3% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses